NASDAQ · Biotechnology

NMAD (NMAD) Stock

$4.02 -9.26% NASDAQ: NMAD Healthcare

Valuation

MetricValue
Price$4.02
Market Cap$49.69M
P/E Ratio-4.97
P/B Ratio7.73
P/S Ratio—
EPS (TTM)$-1.26
52-Week High$8.38
52-Week Low$2.36
Dividend Yield—

Financials & Margins

MetricValue
ROE-60.00%
ROA-46.15%
ROCE-41.67%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue—————
Operating Profit$-7.0M$-6.0M$-5.0M$-4.0M$-5.0M
Net Profit$-7.0M$-6.0M$-5.0M$-4.0M$-6.0M
EPS$-0.50$-3.99$-2.66$-1.59$-1.26
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.0M$6.0M$4.0M$1.0M$13.0M
Total Liabilities$0$0$0$0$2.0M
Cash$5.0M$5.0M$4.0M$4.0M$4.0M
Borrowings—————

Latest News

NOMAD Increases Voyager Fleet Energy Storage by up to 56%, Bringing Eagle and Falcon to 2.025 MWh GlobeNewswire · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-5.0M$-4.0M$-3.0M$-3.0M
Investing Cash Flow————$-3.0M
Financing Cash Flow$4.0M$5.0M$3.0M—$10.0M
Net Cash Flow$0$1.0M$-1.0M$-3.0M$4.0M
Free Cash Flow$-4.0M$-5.0M$-4.0M$-3.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-3.88%
Quick Ratio5.00
Interest Coverage—
Return 1Y42.07%
Return 3Y3.87%
Return 5Y-80.95%

Ownership

Insiders Held7.70%
Institutions Held5.11%
Institutions Float Held5.54%
Institutional HolderSharesReport Date
Scotia Capital Inc.283,1622026-03-31
Renaissance Technologies, LLC93,0002026-03-31
Federation Des Caisses Desjardins Du Quebec64,4872026-03-31
Geode Capital Management, LLC58,8522026-03-31
Citadel Advisors Llc56,5572026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About NMAD

NMAD is headquartered in US.

NMAD stock trades at $4.02 with a market capitalization of $49.69M. The stock is valued at a price-to-earnings (P/E) ratio of -4.97, price-to-book of 7.73. Over the past 52 weeks the stock has ranged between $2.36 and $8.38, and currently trades 52.0% below its 52-week high.

On profitability, NMAD generates a return on equity (ROE) of -60.00%, return on capital employed of -41.67%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides